Assessment of the soluble forms of TNF-α receptors (sTNFR1 and 2) which may provide more accurate information about activation of the TNF-α system revealed that patients with mild cognitive impairment (MCI) who converted to VaD had higher concentrations of these biomarkers compared to those who converted in AD [45]. This evidence concerns the gene TNF and Cognitive impairment.